Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Aug;198(8):755-758.
doi: 10.1007/s00066-022-01948-9. Epub 2022 May 13.

[Phase II study on treatment de-escalation in HPV-associated oropharyngeal cancer]

[Article in German]
Robert Michael Hermann  1 , Hans Christiansen  2
Affiliations
Clinical Trial

[Phase II study on treatment de-escalation in HPV-associated oropharyngeal cancer]

[Article in German]
Robert Michael Hermann et al. Strahlenther Onkol. 2022 Aug.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Tawk B, Debus J, Abdollahi A. Evolution of a paradigm switch in diagnosis and treatment of HPV-driven head and neck cancer-striking the balance between toxicity and cure. Front Pharmacol. 2022;12:753387. doi: 10.3389/fphar.2021.753387. - DOI - PMC - PubMed
    1. Nichols AC, Theurer J, Prisman E, et al. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial. Lancet Oncol. 2021;20:1349–1359. doi: 10.1016/S1470-2045(19)30410-3. - DOI - PubMed
    1. Gillison ML, Trotti AM, Harris J, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019;393:40–50. doi: 10.1016/S0140-6736(18)32779-X. - DOI - PMC - PubMed
    1. Mehanna H, Robinson M, Hartley A, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. 2019;393:51–60. doi: 10.1016/S0140-6736(18)32752-1. - DOI - PMC - PubMed
    1. McDowell L, Magarey MJR, Rischin D. Transoral surgery and deintensified adjuvant therapy: another step in determining its role in the management of human papillomavirus oropharyngeal cancer. J Clin Oncol. 2022;40:114–117. doi: 10.1200/JCO.21.02364. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources